Oncology Pipeline Highlights Database - 2016 Update, provides most up-to-date information on key pipeline products in the global Oncology Drug market. It covers emerging therapies for Oncology indications in active clinical development stages including early and late stage clinical trials.
The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The database presents pipeline by Oncology indications. Key indications covered in this database include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Brain Cancer, Hodgkin's disease, Acute Myeloid Leukemia and Multiple Myeloma.
By Clinical Trial Stages:
The database provides Oncology pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
By Drug Mechanism Classes:
The database provides Oncology pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The database provides Oncology pipeline products by the company.
- Oncology Pipeline by Indication
- Oncology Pipeline by Clinical Trial Phase
- Oncology Pipeline by Drug Mechanism Classes
- Oncology Pipeline by Company
For more information about this report visit http://www.researchandmarkets.com/research/kprz9j/oncology_pipeline